Researchers at the University of East Anglia have developed a urine test which could revolutionise treatment for prostate cancer.
The new test known as ‘PUR’ (Prostate Urine Risk) could diagnose the aggressive cancer and predict whether patients will need treatment years earlier than standard clinical methods.
Common testing currently includes blood tests, physical examinations, an MRI scan or biopsy. This method would mean men could undergo checks every five years, saving thousands from invasive procedures.
- Watch Claire McGlasson's report here:
More than 40,000 men are diagnosed with prostate cancer every year in UK. The study by the university involved 537 men and identified 35 different genes that could signify a risk for the disease. Shea Connell, from the UEA said: "We’re hoping within the next five years we’ll be able to see something that can be used by clinicians.
"Whether or not that’s on a wide NHS scale or within a clinical trial, we certainly hope that will be something we can start using to diagnose men."
- For more prostate cancer information and support head to https://prostatecanceruk.org/